Clinical Trial Update: Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating botulinum toxin type A blockade of the sphenopalatine ganglion for treatment-refractory chronic cluster headache; currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cluster Headache

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Cluster Headache | Phase 3 | Status: RECRUITING